CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

Conditions: Ischemic Heart Failure With Reduced Ejection Fraction Interventions: Device: Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system Sponsors: BioCardia, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials